Citius Pharmaceuticals (CTXR) Change in Cash (2010 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Change in Cash came in at -$3.1 million in Q1 2026, down 191.64% YoY from $3.4 million in Q1 2025, and down 190.26% on a QoQ basis from $3.5 million in Q4 2025.
Citius Pharmaceuticals (CTXR) Change in Cash (2010 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 17 years of Change in Cash data on file, last reported at -$3.1 million in Q1 2026.
- Quarterly Change in Cash fell 191.64% year-over-year to -$3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 136.41% YoY) and the FY2025 annual result came in at $1.0 million, up 104.31% from the prior year.
- Change in Cash fell to -$3.1 million in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $6.1 million in Q2 2025 to a low of -$14.7 million in Q3 2024.
- A 5-year average of -$3.6 million and a median of -$4.8 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2025 — Change in Cash jumped 261.22% — and 2026, when it tumbled 191.64%.
- Tracing CTXR's Change in Cash over 5 years: stood at -$4.8 million in 2022, then retreated by 27.17% to -$6.1 million in 2023, then jumped by 64.93% to -$2.2 million in 2024, then jumped by 261.22% to $3.5 million in 2025, then tumbled by 190.26% to -$3.1 million in 2026.
- The last three Change in Cash figures came in at -$3.1 million (Q1 2026), $3.5 million (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Citius Pharmaceuticals | 15.71 Mn | 15.71 Mn | 1.00 Mn | 12.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.13 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | -1.84 Mn |
| Jun 30, 2025 | 6.06 Mn |
| Mar 31, 2025 | -1.07 Mn |
| Dec 31, 2024 | -2.15 Mn |
| Sep 30, 2024 | -14.66 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | -7.79 Mn |
| Dec 31, 2023 | -6.14 Mn |
| Sep 30, 2023 | -6.80 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | -7.82 Mn |
| Dec 31, 2022 | -4.82 Mn |
| Sep 30, 2022 | -6.33 Mn |
| Jun 30, 2022 | -7.71 Mn |
| Mar 31, 2022 | -9.67 Mn |
| Dec 31, 2021 | -4.65 Mn |
| Sep 30, 2021 | -45.59 Mn |
| Jun 30, 2021 | 11.97 Mn |